Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data
2019 · Genome Medicine · 1,621 citations
https://doi.org/10.1186/s13073-019-0638-6
N
Noel F.C.C. de Miranda
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
267
Papers
8.8K
Citations
45
h-index
101
i10-index
Noel F.C.C. de Miranda is an academic researcher from Leiden University. The author has contributed to research in topics: Immunotherapy and Immune Responses & Cancer Immunotherapy and Biomarkers & CAR-T cell therapy research. The author has an h-index of 45, co-authored 227 publications.
ORCID: 0000-0001-6122-1024Papers by this author
worksAn integrated tumor, immune and microbiome atlas of colon cancer
2023 · Nature Medicine · 185 citations
https://doi.org/10.1038/s41591-023-02324-5
Immunotherapy-activated T cells recruit and skew late-stage activated M1-like macrophages that are critical for therapeutic efficacy
2024 · Cancer Cell · 116 citations
https://doi.org/10.1016/j.ccell.2024.04.011
Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial
2024 · Nature Medicine · 98 citations
https://doi.org/10.1038/s41591-023-02758-x
Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4
2019 · Genome Medicine · 62 citations
https://doi.org/10.1186/s13073-019-0697-8
Autologous dendritic cells pulsed with allogeneic tumour cell lysate induce tumour-reactive T-cell responses in patients with pancreatic cancer: A phase I study
2022 · European Journal of Cancer · 57 citations
https://doi.org/10.1016/j.ejca.2022.03.015
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat